Samir Shah
Dr Samir Shah
Director
Speciality
Hepatology
Qualification
  • MD
  • DM Gastroenterology
Experience
43 Years
Gender
Male
Language Spoken
English
Hindi
Marathi
Location
Mumbai,Parel
Consultation Charges
2850
Book Appointment

About

Dr Samir R Shah is the Director – Department of Transplant Hepatology, HPB, Liver Intensive Care at the Gleneagles hospital, Mumbai, visiting consultant, Breach Candy Hospital and Cumballa Hill Hospital.

He has been awarded the Hargobind Foundation Scholarship and trained in Hepatology and Liver transplant at the Institute of Hepatology, University College London.

He was the first elected Secretary of the Indian Association for Study of the Liver for the period 1995-1997 and has been a Council Member of International Liaison Committee, Asian Pacific Association for the Study of the Liver (APASL).

He has been involved with several international clinical trials on new drug development with presentations in international meetings and publications in peer reviewed journals.

He has been the driving force to co-ordinate efforts to start a cadaveric organ transplant programme in the country and Mumbai in particular.

Member of the Editorial Board of Indian Journal of Gastroenterology, National Advisory Board of the Journal of the Association of Physician of India (JAPI) Editorial Board Member, Journal of Clinical and Experimental Hepatology.

  • Founder Trustee and the Hon.Gen. Secretary of the National Liver Foundation.
  • Founder Member, Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP).
  • Expert, Core Advisory, Group on Viral Hepatitis, ICMR.
  • Member, Technical Resource Group for Viral Hepatitis, MOH and FW,GOI.

Expertise:

  • Treatment of Chronic Hepatitis B,C, Fatty Liver Disease
  • Liver critical care, acute and chronic Liver failure, Hepatic Encephalopathy
  • Alcoholic & Non-alcoholic Liver Diseases
  • Liver Cancer & Hepatobiliary Diseases
  • Liver Transplant & Post Transplant
  • Management of Liver Patients

Experience

  • Nov 2011 to Present
    Director – Department of Transplant Hepatology, HPB, Liver Intensive Care at Gleneagles Hospital, Mumbai
  • 1998 to Present
    Hon. Consultant Gastroenterologist at Breach Candy Hospital, Mumbai
  • May 1995 to 2014
    Consultant Gastroenterologist at Jaslok Hospital and Research Centre
  • June 1986 to June 1997
    Consultant Gastroenterologist at Sir H.N. Hospital
  • Sep 1996 to Nov 1997
    Sr. Registrar, Institute of Hepatology at University College London.

Achievements

  • Has been an instrumental in the set up of a successful liver transplant program at the Gleneagles Hospital Mumbai which has already done 400+ liver transplants.
  • 2017 Expert, Core Advisory, Group on Viral Hepatitis, ICMR.
  • 2017, Member, Technical Resource Group for Viral Hepatitis, MOH and FW, GOI
  • 2011 till date, Head, Department of Hepatology Institute of Liver Diseases, HPB Surgery and Transplant at the Gleneagles hospital Mumbai
  • Founder Member, Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP).
  • 1998, Council Member of International Liaison Committee, Asian Pacific Association for the Study of the Liver (APASL)
  • 1998 till date Founder Trustee and the Hon. Gen. Secretary of the National Liver Foundation.
  • Currently as the Founder Trustee and Hon. General Secretary of National Liver Foundation involved with organizing a nationwide campaign for cadaveric organ donation in addition to increasing awareness and prevention of diseases of the liver.
  • 1997 he has been the driving force to co-ordinate efforts to start a cadaveric organ transplant programme in the country and particularly in Mumbai
  • Member of team which performed first successful liver transplant in Mumbai
  • 1996, Awarded the Hargobind Foundation Scholarship in 1996 and trained in Hepatology and Liver transplant at the Institute of Hepatology, University College London.
  • 1995-1997, elected as First Secretary of the Indian Association for Study of the Liver Active in Indian Association of Study of the Liver, and involved with National Consensus meetings on Management of Hepatitis B, C, NAFLD and HCC.
  • 1994 till date involved with several international clinical trials on new drug development with presentations in international meetings and publications in peer reviewed journals.
  • Member of the Editorial Board of Indian Journal of Gastroenterology, National Advisory Board of the Journal of the Association of Physician of India (JAPI) Editorial Board Member, Journal of Clinical and Experimental Hepatology.

Qualifications

MD, DM, (CMC Vellore)

Publications

Dr Samir R Shah has published more than 40 articles in National and International Journals, some of them are –

  • Ajay Duseja, Samir Shah, Shiv Kumar Sarin, Impact of Metabolic Risk Factors on the Severity and Outcome of Patients with Alcohol Associated Acute on Chronic Liver Failure. Liver international Sept 2020 Liver Int . 2020 Sep 24. doi: 10.1111/liv.14671.
  • Samir Shah, Akash Shukla, FIB-4 cut off of 1.3 may be inappropriate in a primary care referral pathway of patient with nonalcoholic fatty liver disease. Journal of Hepatology 2020;(73):212-224
  • Kumar A, Samir R Shah, Manav Wadhawan INASL Task-Force on Hepatocellular Carcinoma Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations. J Clin Exp Hepatol. 2020;10(1):43‐80.
  • Anand L, Samir R Shah, Shiv K Sarin, APASL ACLF (APASL ACLF Research Consortium) Working Party. Flare of Autoimmune Hepatitis Causing Acute on Chronic Liver Failure: Diagnosis and Response to Corticosteroid Therapy. Hepatology. 2019; 70(2):587‐596.
  • Sneha Kothari, Hiteshi Dhami-Shah, Samir R Shah, Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver Disease. J Clin Exp Hepatol. 2019;9(6):723‐730.
  • Sood A, Samir R Shah, Vivek Saraswat, Sofosbuvir-Velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India. Hepatol Int. 2019;13(2):173‐179.
  • Sarin SK, Samir R Shah, Eileen L Yoon, APASL ACLF Research Consortium (AARC) for APASL ACLF working Party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13(4):353‐390.
  • Harshad Devarbhavi, Samir R Shah, Shiv K Sarin, Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients. Am J Gastroenterol. 2019;114(6):929‐937.
  • Zaheer Amin Virani, Samir R Shah, Bharat V Shah, Successful Outcome of Transplanting a Kidney from a HCV positive Deceased Donor into a HCV –Negative Recipient. Indian Journal of Transplantation. 2018; 12(3) 227-229.
  • Seng Gee Lim, Samir R Shah, Norasiah Abu Bakar, Findings from a large Asian chronic hepatitis C real life study. J Viral Hepat. 2018; 25:1533–1542
  • Lovkesh Anand, Samir R Shah, Shiv K Sarin, Flare of Autoimmune Hepatitis causing acute on chronic liver failure (ACLF): diagnosis and response to corticosteroid therapy. Hepatology 2018; (68): 1-22
  • Tang L,  S Shah, Comparative antiviral efficacy of generic sofosbuvir versus brand name Sofosbuvir with Ribavirin for the treatment of hepatitis C. Hindawi Interdisciplinary Perspectives on Infectious Diseases. 2018; (9124604): 1- 9
  • The Polaris Observatory Collaborators, Global prevalence, treatment and prevention of hepatitis B virus infection in 2016: A modeling Study. Lancet Gastroenterol Hepatol. 2018; 3(6): 383-403.
  • Chetan Kalal, Samir Shah, Sofosbuvir, Peg Interferon & Ribavirin for retreatment of HCV genotype 1b following Sofosbuvir and Ledipasvir Failure. Hepatology. 2018; (67)5: 2049-2050.

Need Help